Cell-based Therapies: A Maturing Market Poised for Growth

Market Insight:  Oded Ben-Joseph, PhD and Echoe Bouta, PhD


The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.  

Recent advances in cell-based therapy technology and FDA approvals have demonstrated the feasibility of  of treating difficult diseases. Given the progress, we examined recent market dynamics in a 3.5-year period starting in January 2015 by analyzing clinical trials, financing events, M&As and IPOs  to assess the overall activity of the sector and interest by venture capitalists and strategic players


View Full Article

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278